Back to 
Jacobs Levy Equity Management, Inc.
Jacobs Levy Equity Management, Inc.
VKTX
2 quarters
Position history for Jacobs Levy Equity Management, Inc.'s holdings in Viking Therapeutics, Inc.
No. Jacobs Levy Equity Management exited its VKTX (Viking Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 487,313 shares worth $1.3M. Jacobs Levy Equity Management first reported VKTX in Q3 2022 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$1.3M
Total Shares Change
-487,313
Quarter-by-Quarter History
Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.